Sort
85,873 grants matching “alzheimers”
The Neuroimmune System in Alzheimer's Disease
$3,811,561Joseph El-Khoury · Massachusetts General Hospital · RF1 · FY2015 · AG
Tau PET imaging in racially/ethnically diverse middle-aged adults
$3,810,773Adam M Brickman · Columbia University Health Sciences · RF1 · FY2018 · AG
National Alzheimer's Coordinating Center
$3,803,284Walter A Kukull · University Of Washington · U24 · FY2023 · AG
Sleep Disruption and Alzheimer's Disease Pathology
$3,802,816Mark R Opp · University Of Colorado · RF1 · FY2019 · AG
Linking peripheral and brain insulin resistance to AD neuropathology and cognition
$3,800,482Zoe Arvanitakis · Rush University Medical Center · RF1 · FY2018 · AG
Alzheimer's Disease Research Center
$3,795,174Thomas J. Grabowski · University Of Washington · P50 · FY2018 · AG
National Alzheimer's Coordinating Center
$3,793,977Walter A Kukull · University Of Washington · U01 · FY2015 · AG
Alzheimer's Disease Genetics Consortium
$3,793,371Gerard David Schellenberg · University Of Pennsylvania · U01 · FY2009 · AG
Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL)
$3,792,731Katie L Stone · California Pacific Med Ctr Res Institute · R01 · FY2024 · AG
Heterogeneity of Multi-modal Imaging Signatures of Aging, MCI, Alzheimer's disease via Pattern Analysis
$3,791,182Christos Davatzikos · University Of Pennsylvania · RF1 · FY2017 · AG
Translating SHIP1 genetics to generate a novel Alzheimer's pharmacologic agent
$3,791,020Steven Estus · University Of Kentucky · RF1 · FY2018 · AG
Alzheimer's Disease Research Center
$3,790,985Thomas J. Grabowski · University Of Washington · P50 · FY2019 · AG
A Nonhuman Primate Model of Early Alzheimer's Disease Pathogenesis
$3,790,223John H Morrison · University Of California At Davis · RF1 · FY2019 · AG
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
$3,789,799Frank R Lin · Johns Hopkins University · R01 · FY2017 · AG
Pathway discovery, validation and compound identification for Alzheimer's disease
$3,789,650Philip L De Jager · Broad Institute, Inc. · U01 · FY2016 · AG
Impact of sex differences in immune function on shared risk for cardiometabolic disorder & Alzheimer's disease
$3,788,451Jill M Goldstein · Massachusetts General Hospital · RF1 · FY2021 · AG
Vanderbilt Memory & Aging Project
$3,787,834Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2021 · AG
Neuroimaging Predictors of Alzheimer's Disease and Cognitive Decline
$3,786,663Susan Resnick · National Institute On Aging · ZIA · FY2019 · AG
Midbrain circuits for perceptual decision-making
$3,784,592Jianhua Cang · University Of Virginia · UF1 · FY2021 · NS
LitCog V: Health Literacy and Cognitive Function Among Older Adults
$3,782,845Michael S Wolf · Northwestern University At Chicago · RF1 · FY2025 · AG
Integrative biobehavioral and psychosocial risk for cognitive decline in the elderly
$3,781,840Christopher G Engeland · Pennsylvania State University, The · RF1 · FY2018 · AG
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II)
$3,779,978Oluwaseun Johnson-Akeju · Massachusetts General Hospital · R01 · FY2025 · AG
Structure and Inhibition of Amyloid in Alzheimer's Disease
$3,779,925David Eisenberg · University Of California Los Angeles · RF1 · FY2016 · AG
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD
$3,776,527Timothy M. Hughes · Wake Forest University Health Sciences · R01 · FY2022 · AG
Comparative genomics of longevity and Alzheimer's disease
$3,776,117Vera Gorbunova · University Of Rochester · P01 · FY2024 · AG